Protein-based therapies for acute lung injury: targeting neutrophil extracellular traps

Bibliography

• Force ADT, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307(23):2526-33
   PubMed Web of Science ®Google Scholar
• Goss CH, Brower RG, Hudson LD, et al. Incidence of acute lung injury in the United States. Crit Care Med 2003;31(6):1607-11
   Google Scholar
• Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005;353(16):1685-93
   PubMed Web of Science ®Google Scholar
• Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342(18):1301-8
   PubMed Web of Science ®Google Scholar
• National Heart L; Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N, Wiedemann HP, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006;354(24):2564-75
   PubMed Web of Science ®Google Scholar
• Rice TW, Wheeler AP, Thompson BT, et al. Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA 2011;306(14):1574-81
   PubMed Web of Science ®Google Scholar
• National Heart L; Blood Institute Acute Respiratory Distress Syndrome Clinical Trials NMatthay MA, et al. Randomized, placebo-controlled clinical trial of an aerosolized beta(2)-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 2011;184(5):561-8
   Google Scholar
• Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012;122(8):2731-40
   PubMed Web of Science ®Google Scholar
• Ward PA. Acute lung injury: how the lung inflammatory response works. Eur Respir J Suppl 2003;44:22s-3s
   PubMedGoogle Scholar
• Gao H, Neff T, Ward PA. Regulation of lung inflammation in the model of IgG immune-complex injury. Annu Rev Pathol 2006;1:215-42
   PubMed Web of Science ®Google Scholar
• Corada M, Mariotti M, Thurston G, et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci USA 1999;96(17):9815-20
   PubMed Web of Science ®Google Scholar
• Shaw JO, Henson PM. Pulmonary intravascular sequestration of activated neutrophils: failure to induce light-microscopic evidence of lung injury in rabbits. Am J Pathol 1982;108(1):17-23
   Google Scholar
• Garibaldi BT, D'Alessio FR, Mock JR, et al. Regulatory T cells reduce acute lung injury fibroproliferation by decreasing fibrocyte recruitment. Am J Respir Cell Mol Biol 2013;48(1):35-43
   Google Scholar
• Imai Y, Kuba K, Neely GG, et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008;133(2):235-49
   PubMed Web of Science ®Google Scholar
• Chabot F, Mitchell JA, Gutteridge JM, et al. Reactive oxygen species in acute lung injury. Eur Respir J 1998;11(3):745-57
   PubMed Web of Science ®Google Scholar
• Warren JS, Yabroff KR, Remick DG, et al. Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J Clin Invest 1989;84(6):1873-82
   PubMed Web of Science ®Google Scholar
• Bosmann M, Grailer JJ, Ruemmler R, et al. Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury. FASEB J 2013;27(12):5010-21
   PubMed Web of Science ®Google Scholar
• Chen ES, Greenlee BM, Wills-Karp M, et al. Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin. Am J Respir Cell Mol Biol 2001;24(5):545-55
   PubMed Web of Science ®Google Scholar
• Bastarache JA, Sebag SC, Grove BS, et al. Interferon-gamma and tumor necrosis factor-alpha act synergistically to up-regulate tissue factor in alveolar epithelial cells. Exp Lung Res 2011;37(8):509-17
   PubMed Web of Science ®Google Scholar
• Bardales RH, Xie SS, Schaefer RF, et al. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol 1996;149(3):845-52
   Google Scholar
• Polunovsky VA, Chen B, Henke C, et al. Role of mesenchymal cell death in lung remodeling after injury. J Clin Invest 1993;92(1):388-97
   Google Scholar
• Curley GF, Hayes M, Ansari B, et al. Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax 2012;67(6):496-501
   PubMed Web of Science ®Google Scholar
• Gotts JE, Matthay MA. Mesenchymal stem cells and acute lung injury. Crit Care Clin 2011;27(3):719-33
   Google Scholar
• Liu KD, Levitt J, Zhuo H, et al. Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med 2008;178(6):618-23
   PubMed Web of Science ®Google Scholar
• Paine R III, Standiford TJ, Dechert RE, et al. A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury. Crit Care Med 2012;40(1):90-7
   PubMed Web of Science ®Google Scholar
• Spragg RG, Lewis JF, Walmrath HD, et al. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004;351(9):884-92
   PubMed Web of Science ®Google Scholar
• Gao Smith F, Perkins GD, Gates S, et al. Effect of intravenous beta-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2012;379(9812):229-35
   PubMed Web of Science ®Google Scholar
• Bernard GR, Luce JM, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987;317(25):1565-70
   PubMed Web of Science ®Google Scholar
• Bernard GR, Wheeler AP, Arons MM, et al. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. Chest 1997;112(1):164-72
   PubMed Web of Science ®Google Scholar
• Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006;354(16):1671-84
   PubMed Web of Science ®Google Scholar
• Nonaka M, Yoshizaki F. Evolution of the complement system. Mol Immunol 2004;40(12):897-902
   Google Scholar
• Bosmann M, Ward PA. Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsis. Adv Exp Med Biol 2012;946:147-59
   PubMed Web of Science ®Google Scholar
• Mulligan MS, Schmid E, Beck-Schimmer B, et al. Requirement and role of C5a in acute lung inflammatory injury in rats. J Clin Invest 1996;98(2):503-12
   Google Scholar
• Campbell WD, Lazoura E, Okada N, et al. Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. Microbiol Immunol 2002;46(2):131-4
   PubMed Web of Science ®Google Scholar
• Zwirner J, Gotze O, Sieber A, et al. The human mast cell line HMC-1 binds and responds to C3a but not C3a(desArg). Scand J Immunol 1998;47(1):19-24
   Google Scholar
• Gerard NP, Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature 1991;349(6310):614-17
   PubMed Web of Science ®Google Scholar
• Okinaga S, Slattery D, Humbles A, et al. C5L2, a nonsignaling C5A binding protein. Biochemistry 2003;42(31):9406-15
   PubMed Web of Science ®Google Scholar
• Li R, Coulthard LG, Wu MC, et al. C5L2: a controversial receptor of complement anaphylatoxin, C5a. FASEB J 2013;27(3):855-64
   PubMed Web of Science ®Google Scholar
• Ward PA. Immune complex injury of the lung. Am J Pathol 1979;97(1):85-92
   Google Scholar
• Larsen GL, McCarthy K, Webster RO, et al. A differential effect of C5a and C5a des Arg in the induction of pulmonary inflammation. Am J Pathol 1980;100(1):179-92
   Google Scholar
• Till GO, Johnson KJ, Kunkel R, et al. Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. J Clin Invest 1982;69(5):1126-35
   Google Scholar
• Vogel CW, Fritzinger DC, Hew BE, et al. Recombinant cobra venom factor. Mol Immunol 2004;41(2-3):191-9
   PubMedGoogle Scholar
• Stevens JH, O'Hanley P, Shapiro JM, et al. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J Clin Invest 1986;77(6):1812-16
   Google Scholar
• Weinberg PF, Matthay MA, Webster RO, et al. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome. Am Rev Respir Dis 1984;130(5):791-6
   Google Scholar
• Bozic CR, Lu B, Hopken UE, et al. Neurogenic amplification of immune complex inflammation. Science 1996;273(5282):1722-5
   PubMed Web of Science ®Google Scholar
• Trujillo G, Habiel DM, Ge L, et al. Neutrophil recruitment to the lung in both C5a- and CXCL1-induced alveolitis is impaired in vitamin D-binding protein-deficient mice. J Immunol 2013;191(2):848-56
   Google Scholar
• Klaff LS, Gill SE, Wisse BE, et al. Lipopolysaccharide-induced lung injury is independent of serum vitamin D concentration. PLoS One 2012;7(11):e49076
   Google Scholar
• Shushakova N, Eden G, Dangers M, et al. The urokinase/urokinase receptor system mediates the IgG immune complex-induced inflammation in lung. J Immunol 2005;175(6):4060-8
   Google Scholar
• Addis-Lieser E, Kohl J, Chiaramonte MG. Opposing regulatory roles of complement factor 5 in the development of bleomycin-induced pulmonary fibrosis. J Immunol 2005;175(3):1894-902
   Google Scholar
• Gerard NP, Lu B, Liu P, et al. An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2. J Biol Chem 2005;280(48):39677-80
   PubMed Web of Science ®Google Scholar
• Bosmann M, Haggadone MD, Hemmila MR, et al. Complement activation product C5a is a selective suppressor of TLR4-induced, but not TLR3-induced, production of IL-27(p28) from macrophages. J Immunol 2012;188(10):5086-93
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science 2004;303(5663):1532-5
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol 2007;5(8):577-82
   PubMed Web of Science ®Google Scholar
• Fuchs TA, Abed U, Goosmann C, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007;176(2):231-41
   PubMed Web of Science ®Google Scholar
• Clark SR, Ma AC, Tavener SA, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007;13(4):463-9
   PubMed Web of Science ®Google Scholar
• Urban CF, Reichard U, Brinkmann V, et al. Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell Microbiol 2006;8(4):668-76
   PubMed Web of Science ®Google Scholar
• Bruns S, Kniemeyer O, Hasenberg M, et al. Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA. PLoS Pathog 2010;6(4):e1000873
   PubMed Web of Science ®Google Scholar
• McCormick A, Heesemann L, Wagener J, et al. NETs formed by human neutrophils inhibit growth of the pathogenic mold Aspergillus fumigatus. Microbes Infect 2010;12(12-13):928-36
   PubMed Web of Science ®Google Scholar
• Beiter K, Wartha F, Albiger B, et al. An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps. Curr Biol 2006;16(4):401-7
   PubMed Web of Science ®Google Scholar
• Xu J, Zhang X, Pelayo R, et al. Extracellular histones are major mediators of death in sepsis. Nat Med 2009;15(11):1318-21
   PubMed Web of Science ®Google Scholar
• Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 2011;29:139-62
   PubMed Web of Science ®Google Scholar
• Klune JR, Dhupar R, Cardinal J, et al. HMGB1: endogenous danger signaling. Mol Med 2008;14(7-8):476-84
   PubMed Web of Science ®Google Scholar
• Hakkim A, Fuchs TA, Martinez NE, et al. Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation. Nat Chem Biol 2011;7(2):75-7
   PubMed Web of Science ®Google Scholar
• McInturff AM, Cody MJ, Elliott EA, et al. Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction of hypoxia-inducible factor 1 alpha. Blood 2012;120(15):3118-25
   PubMed Web of Science ®Google Scholar
• Li P, Li M, Lindberg MR, et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med 2010;207(9):1853-62
   PubMed Web of Science ®Google Scholar
• Neeli I, Khan SN, Radic M. Histone deimination as a response to inflammatory stimuli in neutrophils. J Immunol 2008;180(3):1895-902
   PubMed Web of Science ®Google Scholar
• Saffarzadeh M, Juenemann C, Queisser MA, et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One 2012;7(2):e32366
   PubMed Web of Science ®Google Scholar
• Caudrillier A, Kessenbrock K, Gilliss BM, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 2012;122(7):2661-71
   PubMed Web of Science ®Google Scholar
• Abrams ST, Zhang N, Manson J, et al. Circulating Histones Are Mediators of Trauma-associated Lung Injury. Am J Respir Crit Care Med 2013;187(2):160-9
   PubMed Web of Science ®Google Scholar
• Allam R, Scherbaum CR, Darisipudi MN, et al. Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol 2012;23(8):1375-88
   PubMed Web of Science ®Google Scholar
• Xu J, Zhang X, Monestier M, et al. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J Immunol 2011;187(5):2626-31
   PubMed Web of Science ®Google Scholar
• Garcia CC, Weston-Davies W, Russo RC, et al. Complement C5 activation during influenza A infection in mice contributes to neutrophil recruitment and lung injury. PLoS One 2013;8(5):e64443
   PubMed Web of Science ®Google Scholar
• Fuchs TA, Brill A, Duerschmied D, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA 2010;107(36):15880-5
   PubMed Web of Science ®Google Scholar
• von Bruhl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012;209(4):819-35
   PubMed Web of Science ®Google Scholar
• Fuchs TA, Kremer Hovinga JA, Schatzberg D, et al. Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood 2012;120(6):1157-64
   PubMed Web of Science ®Google Scholar
• Li MO, Wan YY, Sanjabi S, et al. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006;24:99-146
   PubMed Web of Science ®Google Scholar
• Rifkin DB. Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability. J Biol Chem 2005;280(9):7409-12
   PubMed Web of Science ®Google Scholar
• Stockis J, Colau D, Coulie PG, et al. Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg. Eur J Immunol 2009;39(12):3315-22
   PubMed Web of Science ®Google Scholar
• Pittet JF, Griffiths MJ, Geiser T, et al. TGF-beta is a critical mediator of acute lung injury. J Clin Invest 2001;107(12):1537-44
   PubMed Web of Science ®Google Scholar
• Schultz-Cherry S, Murphy-Ullrich JE. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol 1993;122(4):923-32
   PubMed Web of Science ®Google Scholar
• Barcellos-Hoff MH, Dix TA. Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol 1996;10(9):1077-83
   PubMedGoogle Scholar
• Karsdal MA, Larsen L, Engsig MT, et al. Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J Biol Chem 2002;277(46):44061-7
   Web of Science ®Google Scholar
• Wrana JL, Attisano L, Wieser R, et al. Mechanism of activation of the TGF-beta receptor. Nature 1994;370(6488):341-7
   PubMed Web of Science ®Google Scholar
• Wang XF, Lin HY, Ng-Eaton E, et al. Expression cloning and characterization of the TGF-beta type III receptor. Cell 1991;67(4):797-805
   Google Scholar
• Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997;390(6659):465-71
   PubMed Web of Science ®Google Scholar
• Birukova AA, Adyshev D, Gorshkov B, et al. ALK5 and Smad4 are involved in TGF-beta1-induced pulmonary endothelial permeability. FEBS Lett 2005;579(18):4031-7
   Google Scholar
• Perlman R, Schiemann WP, Brooks MW, et al. TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat Cell Biol 2001;3(8):708-14
   Google Scholar
• Hannigan M, Zhan L, Ai Y, et al. The role of p38 MAP kinase in TGF-beta1-induced signal transduction in human neutrophils. Biochem Biophys Res Commun 1998;246(1):55-8
   Google Scholar
• Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992;359(6397):693-9
   PubMed Web of Science ®Google Scholar
• Murray LA, Chen Q, Kramer MS, et al. TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P. Int J Biochem Cell Biol 2011;43(1):154-62
   PubMed Web of Science ®Google Scholar
• Frank J, Roux J, Kawakatsu H, et al. Transforming growth factor-beta1 decreases expression of the epithelial sodium channel alphaENaC and alveolar epithelial vectorial sodium and fluid transport via an ERK1/2-dependent mechanism. J Biol Chem 2003;278(45):43939-50
   Google Scholar
• Pittet JF, Koh H, Fang X, et al. HMGB1 accelerates alveolar epithelial repair via an IL-1beta- and alphavbeta6 integrin-dependent activation of TGF-beta1. PLoS One 2013;8(5):e63907
   Google Scholar
• Bartram U, Speer CP. The role of transforming growth factor beta in lung development and disease. Chest 2004;125(2):754-65
   PubMed Web of Science ®Google Scholar
• Adamali HI, Maher TM. Current and novel drug therapies for idiopathic pulmonary fibrosis. Drug Des Devel Ther 2012;6:261-72
   PubMed Web of Science ®Google Scholar
• Postlethwaite AE, Keski-Oja J, Moses HL, et al. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med 1987;165(1):251-6
   Google Scholar
• Desmouliere A, Geinoz A, Gabbiani F, et al. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993;122(1):103-11
   PubMed Web of Science ®Google Scholar
• Willis BC, Liebler JM, Luby-Phelps K, et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 2005;166(5):1321-32
   PubMed Web of Science ®Google Scholar
• Zhang HY, Phan SH. Inhibition of myofibroblast apoptosis by transforming growth factor beta(1). Am J Respir Cell Mol Biol 1999;21(6):658-65
   PubMed Web of Science ®Google Scholar
• Kramann R, DiRocco DP, Humphreys BD. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease. J Pathol 2013;231(3):273-89
   Google Scholar
• Garcia-Alvarez J, Ramirez R, Checa M, et al. Tissue inhibitor of metalloproteinase-3 is up-regulated by transforming growth factor-beta1 in vitro and expressed in fibroblastic foci in vivo in idiopathic pulmonary fibrosis. Exp Lung Res 2006;32(5):201-14
   PubMed Web of Science ®Google Scholar
• Taylor LM, Khachigian LM. Induction of platelet-derived growth factor B-chain expression by transforming growth factor-beta involves transactivation by Smads. J Biol Chem 2000;275(22):16709-16
   Google Scholar
• Dhainaut JF, Charpentier J, Chiche JD. Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome. Crit Care Med 2003;31(4 Suppl):S258-64
   Google Scholar
• Peng R, Sridhar S, Tyagi G, et al. Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for “active” disease. PLoS One 2013;8(4):e59348
   PubMed Web of Science ®Google Scholar
• STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF). Available from: http://clinicaltrialsgov/ct2/show/study/NCT01371305
   Google Scholar
• Nauseef WM. Editorial: nyet to NETs? A pause for healthy skepticism. J Leukoc Biol 2012;91(3):353-5
   Google Scholar
• Buchanan JT, Simpson AJ, Aziz RK, et al. DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr Biol 2006;16(4):396-400
   PubMed Web of Science ®Google Scholar
• Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med 2009;361(1):62-72
   PubMed Web of Science ®Google Scholar
• Hirsch JG. Bactericidal action of histone. J Exp Med 1958;108(6):925-44
   PubMed Web of Science ®Google Scholar
• Hillmen P, Young NS, Schubert J, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006;355(12):1233-43
   PubMed Web of Science ®Google Scholar
• Smirnova I, Poltorak A, Chan EK, et al. Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol 2000;1(1):RESEARCH002
   PubMed Web of Science ®Google Scholar
• Looney MR, Gropper MA, Matthay MA. Transfusion-related acute lung injury: a review. Chest 2004;126(1):249-58
   Web of Science ®Google Scholar
• Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008;295(3):L379-99
   PubMed Web of Science ®Google Scholar
• Bosmann M, Grailer JJ, Zhu K, et al. Anti-inflammatory effects of beta2 adrenergic receptor agonists in experimental acute lung injury. FASEB J 2012;26(5):2137-44
   Google Scholar
• Corbel M, Lagente V, Theret N, et al. Comparative effects of betamethasone, cyclosporin and nedocromil sodium in acute pulmonary inflammation and metalloproteinase activities in bronchoalveolar lavage fluid from mice exposed to lipopolysaccharide. Pulm pharmacol Ther 1999;12(3):165-71
   Google Scholar
• Singh B, Tiwari AK, Singh K, et al. beta2 agonist for the treatment of acute lung injury: a systematic review and meta-analysis. Respir Care 2014;59(2):288-96
   PubMed Web of Science ®Google Scholar
• Taylor RW, Zimmerman JL, Dellinger RP, et al. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 2004;291(13):1603-9
   PubMed Web of Science ®Google Scholar
• Abraham E, Baughman R, Fletcher E, et al. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group. Crit Care Med 1999;27(8):1478-85
   PubMed Web of Science ®Google Scholar